4.5 Interaction with other medicinal products and other forms of interaction  
 The potential for interactions with other medicines is low, based on the known el imination pathway of zanamivir.  
 Zanamivir is not a substrate, inhibitor or inducer of cytochrome P450 isoenzymes nor a substrate or inhibitor of renal and hepatic transporters  at clinically relevant concentrations (see section 5.2) . 
 
 
